|
ALMR Alamar Biosciences Inc 2104204 |
| Balance Sheet |
|
Current Assets
|
$331,382,000.00 |
|
Assets
|
$390,975,000.00 |
|
Current Liabilities
|
$27,960,000.00 |
|
Liabilities
|
$78,118,000.00 |
|
Equity
|
$312,857,000.00 |
|
Shares Out
|
69392766.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-31,669,000.00 |
|
Investing Cash Flow
|
$-121,574,000.00 |
| Market Analysis |
Market Cap
|
$2,403,765,414.24 |
|
Price
|
$34.64 |
|
BVPS
|
4.51 |
|
PB
|
7.68 |
|
EPS
|
-0.22 |
|
PS
|
20.42 |
|
FCF
|
$-35,911,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:33 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:23 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-08 |
-1.74 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ALMR documents filed with the SEC.
ALMR Filings
Clear
